Evidence map›Paper›PMID 25666935›Full record

ArticleEndocrine2015

MiR-346 regulates CD4⁺CXCR5⁺ T cells in the pathogenesis of Graves' disease.

Juan Chen, Jie Tian, Xinyi Tang, Ke Rui, Jie Ma, Chaoming Mao, Yingzhao Liu, Liwei Lu, Huaxi Xu, Shengjun Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterizing the Interplay of Lymphocytes in Graves' Disease.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Observational
  9. Review
  10. Article
  11. New Insights into Mechanisms of Endocrine-Disrupting Chemicals in Thyroid Diseases: The Epigenetic Way.International journal of environmental research and public health · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Epigenetics and Autoimmune Thyroid Diseases.Frontiers in endocrinology · 2017
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Juan ChenDepartment of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, 212002, Jiangsu Province, China.
Jie Tian
Xinyi Tang
Ke Rui
Jie Ma
Chaoming Mao
Yingzhao Liu
Liwei Lu
Huaxi Xu
Shengjun Wang
Jiangsu University · CNAffiliated Hospital of Jiangsu University · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follicular helper T (Tfh) cells are increasingly recognized as participants in various autoimmune diseases, including Graves' disease. Although many transcription factors and cytokines are known to regulate Tfh cells, the role of noncoding RNA in Tfh cells development and function is poorly understood. Twenty-three patients with GD, eleven patients with remitting GD, and twenty-four healthy controls were enrolled in the current study. The interaction of miRNA and target gene was predicted through software analysis and then validated by luciferase assay and Western blot. The levels of miR-346 in circulating CD4(+) T cells and plasma were measured by qRT-PCR. The correlation of miR-346 levels with the percentages of CD4(+)CXCR5(+)T cells and autoantibody levels were also analyzed. Up-regulation of Bcl-6 and down-regulation of miR-346 in GD patients were observed, and miR-346 could inhibit Bcl-6 at both transcriptional and translational levels. Overexpression of miR-346 led to attenuating CD4(+)CXCR5(+) T cells. The abnormal expression of miR-346 restored in GD patients after treatment. A negative correlation between levels of miR-346 and percentages of CD4(+)CXCR5(+) T cells was confirmed in GD patients. Additionally, negative correlations between the levels of miR-346 in circulating CD4(+) T cells and serum concentrations of TR-Ab, TG-Ab, and TPO-Ab were also revealed in GD patients. MiR-346 regulates CD4(+)CXCR5(+) T cells by targeting Bcl-6, a positive regulator of Tfh cells, and might play an important role in the pathogenesis of Graves' disease.

Indexed as

AdultAgedAutoantibodiesCD4-Positive T-LymphocytesFemaleFlow CytometryGraves DiseaseHumansJurkat CellsMaleMicroRNAsMiddle AgedProto-Oncogene Proteins c-bcl-6Real-Time Polymerase Chain ReactionReceptors, CXCR5ThyroglobulinAutoantibodiesCXCR5 protein, humanMicroRNAsMIRN346 microRNA, humanProto-Oncogene Proteins c-bcl-6Receptors, CXCR5Thyroglobulin

Identifiers

PMID25666935
OpenAlexW2075937951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.